Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Combs

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Biotechnology Progress|February 12, 2011
Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cellsRodney G Combs, Erwin Yu, Susanna Roe, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWPJ A Radosevich, S G Combs, Y Ma, et al.
Current Problems in Cardiology|October 31, 2021
Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on VorapaxarRahul Gupta, Muling Lin, Anila Mehta, et al.
Epidemiology and Infection|January 24, 1998
The prevalence of Serpulina pilosicoli in humans and domestic animals in the Eastern Highlands of Papua New GuineaD J Trott, B G Combs, A S Mikosza, et al.
The Journal of Biological Chemistry|February 13, 2002
IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2Nandini Kishore, Q Khai Huynh, Sumathy Mathialagan, et al.
Thrombosis and Haemostasis|March 1, 1994
Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coliJ A Diaz-Collier, M O Palmier, K K Kretzmer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 16, 2022
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsAaqib H Malik, Rahul Gupta, Sandipan Chakraborty, et al.
Cardiology in Review|February 17, 2022
Robotic Assisted Versus Manual Percutaneous Coronary Intervention: Systematic Review and Meta-AnalysisRahul Gupta, Aaqib H Malik, Jeffrey Shi Kai Chan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 22, 2023
Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysisRahul Gupta, Elham Mahmoudi, Amir Hossein Behnoush, et al.
The Journal of Biological Chemistry|May 24, 2000
Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activityQ K Huynh, H Boddupalli, S A Rouw, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Biotechnology Progress|February 12, 2011
Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cellsRodney G Combs, Erwin Yu, Susanna Roe, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1989
Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWPJ A Radosevich, S G Combs, Y Ma, et al.
Current Problems in Cardiology|October 31, 2021
Protease-Activated Receptor Antagonist for Reducing Cardiovascular Events - A Review on VorapaxarRahul Gupta, Muling Lin, Anila Mehta, et al.
Epidemiology and Infection|January 24, 1998
The prevalence of Serpulina pilosicoli in humans and domestic animals in the Eastern Highlands of Papua New GuineaD J Trott, B G Combs, A S Mikosza, et al.
The Journal of Biological Chemistry|February 13, 2002
IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2Nandini Kishore, Q Khai Huynh, Sumathy Mathialagan, et al.
Thrombosis and Haemostasis|March 1, 1994
Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coliJ A Diaz-Collier, M O Palmier, K K Kretzmer, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 16, 2022
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsAaqib H Malik, Rahul Gupta, Sandipan Chakraborty, et al.
Cardiology in Review|February 17, 2022
Robotic Assisted Versus Manual Percutaneous Coronary Intervention: Systematic Review and Meta-AnalysisRahul Gupta, Aaqib H Malik, Jeffrey Shi Kai Chan, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 22, 2023
Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysisRahul Gupta, Elham Mahmoudi, Amir Hossein Behnoush, et al.
The Journal of Biological Chemistry|May 24, 2000
Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activityQ K Huynh, H Boddupalli, S A Rouw, et al.
Pageof 6